Medicinova Inc (MNOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,845 | -9,195 | -4,029 | -10,961 | -17,734 |
| Depreciation Amortization | 27 | 40 | 97 | -733 | 794 |
| Accounts receivable | -285 | 6,009 | -6,009 | N/A | N/A |
| Accounts payable and accrued liabilities | -109 | 1,152 | -510 | -777 | -656 |
| Other Working Capital | -394 | 8,347 | -7,914 | -881 | 2,259 |
| Other Operating Activity | 2,454 | -5,536 | 7,717 | 1,487 | 2,029 |
| Operating Cash Flow | $-7,152 | $817 | $-10,647 | $-11,864 | $-13,309 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -4 | -37 | -83 | -6 |
| Purchase Of Investment | N/A | N/A | N/A | -680 | N/A |
| Investing Cash Flow | $-2 | $-4 | $-37 | $-763 | $-6 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 77 |
| Common Stock Issued | 17,564 | 4,162 | 13,371 | 1,545 | 9,723 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -9,644 |
| Financing Cash Flow | $17,564 | $4,162 | $13,371 | $1,545 | $156 |
| Exchange Rate Effect | -2 | -6 | 3 | N/A | N/A |
| Beginning Cash Position | 11,669 | 6,701 | 4,011 | 15,093 | 28,252 |
| End Cash Position | 22,077 | 11,669 | 6,701 | 4,011 | 15,093 |
| Net Cash Flow | $10,407 | $4,969 | $2,690 | $-11,083 | $-13,159 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,152 | 817 | -10,647 | -11,864 | -13,309 |
| Capital Expenditure | -2 | -4 | -42 | -83 | -6 |
| Free Cash Flow | -7,155 | 813 | -10,688 | -11,948 | -13,315 |